1
Efficacy and Safety of Patidegib Gel 2% for Preventing Basal Cell Carcinomas on the Face of Adults With Gorlin Syndrome
Condition(s):Gorlin SyndromeLast Updated:February 9, 2024Recruiting
Hide Studies Not Open or Pending
Condition(s):Gorlin SyndromeLast Updated:February 9, 2024Recruiting
Condition(s):Recurrent Basal Cell CarcinomaLast Updated:May 31, 2023Terminated
Condition(s):Basal Cell Nevus SyndromeLast Updated:March 8, 2021Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.